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Previous studies have shown that high-fat diet (HFD)-induced obesity increases the acetoacetyl-CoA
synthetase (AACS) gene expression in lipogenic tissue. To investigate the effect of obesity on the AACS
gene in other tissues, we examined the alteration of AACS mRNA levels in HFD-fed mice. In situ hy-
bridization revealed that AACS was observed in several regions of the embryo, including the backbone
region (especially in the somite), and in the epiphysis of the adult femur. AACS mRNA expression in the
adult femur was higher in HFD-fed mice than in normal-diet fed mice, but this increase was not observed
in high sucrose diet (HSD)-induced obese mice. In addition, HFD-speciﬁc increases were observed in the
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and interleukin (IL)-6 genes. Moreover, we
detected higher AACS mRNA expression in the differentiated osteoclast cells (RAW 264), and found that
AACS mRNA expression was signiﬁcantly up-regulated by IL-6 treatment only in osteoclasts. These re-
sults indicate the novel function of the ketone body in bone metabolism. Because the abnormal acti-
vation of osteoclasts by IL-6 induces bone resorption, our data suggest that AACS and ketone bodies are
important factors in the relationship between obesity and osteoporosis.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
High-fat diet (HFD)-induced obesity has now emerged as a
major risk factor for lifestyle-related disease, such as cardiovascular
disease, stroke, and non-insulin-dependent diabetes mellitus
(NIDDM). These disorders induce unusual metabolism of carbohy-
drates, lipids, and ketone bodies [1]. Because fatty acids and these
metabolites are increased in the circulating serum of obese animals
and owing to the onset of lifestyle-related disease, it is now widely
recognized that fatty acid metabolism lies at the heart of a complex
network that participates in the regulation of a variety of quite
diverse biological functions.
Recently, several reports have suggested that diet-induced
obesity triggers bone metabolic disorders. For example, HFD-fed
mice had lower serum levels of bone formation markers, such as
procollagen type 1 N-terminal propeptide (P1PN) and osteocalcin,mistry, Hoshi University, 2-4-
aki).
nces, Ritsumeikan University,
Inc. This is an open access article uand palmitic acids reduced osteoblast mineralization activity [2]. In
obese humans, ectopic and serum lipid levels are positively corre-
lated with bonemarrow fat [3]. On the other hand, statin therapy to
lower hyperlipidemia is associated with increased bone-mineral
density and decreased fracture risk [4]. These facts indicate that a
high level of serum lipids can be a risk factor for bone disease, such
as osteoporosis. However, more research is required to explore the
association between obesity and bone loss.
Lipid oxidation produces ketone bodies, D()-b-hydrox-
ybutyrate and acetoacetate as byproducts [5]. Thus, elevation of the
serum ketone level is a sign that a tissue is using fat for energy
instead of using glucose under conditions of insulin resistance,
fasting or high-fat feeding. These metabolites have been regarded
as energy sources, andmitochondrial succinyl-CoA: 3-oxoacid CoA-
transferase (SCOT, EC 2.8.3.5) is known to be the enzyme respon-
sible for the activation of acetoacetate for energy generation [6]. On
the other hand, in the cytosol, acetoacetate is known to be directly
activated through the ligase reaction catalyzed by acetoacetyl-CoA
synthetase (acetoacetate-CoA ligase, EC 6.2.1.16; AACS) [7,8] for the
synthesis of biologically important lipogenic substances, such as
cholesterol and fatty acids [9]. In fact, we have previously shownnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and cholesterol production in the liver [10,11]. These facts suggest
that AACS plays important roles in lipid biosynthesis in lipogenic
tissues. However, the pathological and physiological roles of AACS
in adipose tissues have not yet been fully clariﬁed.
We previously found that the expression of AACS mRNA in
subcutaneous white adipose tissue was increased in high-fat diet-
induced obese rodents [12]. Morbid obesity causes a metabolic
disorder, which includes unusual lipogenesis and ketogenesis [1].
We have also demonstrated that feeding rats pravastatin markedly
increased the hepatic AACS activity and decreased the level of
plasma ketone bodies in the diabetic rats [13]. Statins are
commonly prescribed drugs that inhibit 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMGCR) and decrease he-
patic cholesterol biosynthesis. Mundy et al. revealed that statins
enhance new bone formation in rodents [14]. Because AACS might
be related to obesity-induced disorders of energy metabolism, such
as lipid and ketone body utilization, we thought that AACS might
also be related to bone formation via the ketone-cholesterol
metabolic pathway. To clarify the relationship between AACS and
bone metabolism in obesity, we investigated whether the obesity
affects AACS gene expression in the femurs of mice.
2. Materials and methods
2.1. Animals
Mice of the ddY strain were purchased from the Tokyo Labora-
tory Animals Science Co., Ltd. (Tokyo, Japan). The present study was
conducted in accordance with the Guiding Principles for the Care
and Use of Laboratory Animals adopted by the Committee on An-
imal Research of Hoshi University, which is accredited by the
Ministry of Education, Culture, Sports, Science and Technology of
Japan.
2.2. In situ hybridization
Mouse embryos (E16.5) and adult mouse femurs (7 weeks old)
were frozen in powdered dry ice. The sagittal sections were cut at a
thickness of 16 mmusing a cryostat and thaw-mounted onto poly-L-
lysine-coated slides. In situ hybridaization was performed as
described previously [15].
2.3. Preparation of probes for in situ hybridization
The cDNA fragment of mouse AACS, SCOT, HMGCR and osteo-
calcin were ampliﬁed from mouse liver or femur cDNA. The oligo-
nucleotide primers used for ampliﬁcation were: forward
(tccgcaaccatgtccaagct) and reverse (atcacatgcacagctggatg) for
mouse AACS, forward (cgaagatggcggctctcaaa) and reverse
(gatgcttcaagttgaaatct) for mouse SCOT, forward (agagttt-
gaccgccttccga) and reverse (gtcagccagacttcttcaga) for mouse for
HMGCR, and forward (ctcctgaaggtctcacaatc) and reverse (agggt-
taagctcacactgct) for mouse for osteocalcin. The fragments were
cloned into the pGEM-T vector (Promega Co., WI, U.S.A.). 35S-
labeled cRNA probe was transcribed from the cDNA as template
using SP6 or T7 RNA polymerase (Takara Bio, Shiga, Japan) in the
presence of 50-a-[35S] thiotriphosphate (30 TBq/mmol) (Perkin
Elmer, MA, U.S.A.). The probe was shortened to an average length of
200 bases by alkaline hydrolysis.
2.4. Diet-induced obese mouse
Four-week-old male mice of the ddY strain (Tokyo Laboratory
Animals Science Co.) were used after acclimatization for at least 3days. They were given food and tap water ad libitum and main-
tained on a lightedark cycle of 12 h (light on at 8 a.m.). To induce
obesity nutritionally, the mice were given a high-fat chow (type
F2HFD2, Oriental Yeast Co., Tokyo, Japan; 60.0% fat, 24.5% protein,
and 7.5% carbohydrate) or high-sucrose chow (type F2HScD, Ori-
ental Yeast Co.; 2.5% fat, 12.0% protein, and 77.0% carbohydrate) for
12 weeks. The control mice were fed a regular chow (type MF,
Oriental Yeast Co.; 5% fat, 24% protein, and 54% carbohydrate) for
the same period. Then, the animals were killed; the femur bones
were excised for in situ hybridization and RT-PCR.
2.5. Preparation of RNA
RNA was prepared from the mouse femurs and cell cultures
using ISOGEN (Nippon gene, Tokyo, Japan). The RNA integrity was
conﬁrmed by electrophoresis on a denaturing agarose gel con-
taining formaldehyde.
2.6. Measurement of plasma glucose and total ketone bodies
The plasma glucose concentration was determined using a
glucose assay kit (Glucose CII-Test Wako, Wako Pure Chemical In-
dustries, Tokyo, Japan), which was developed from the mutarotase-
glucose oxidase method [16]. Determination of plasma ketone
bodies [17] was carried out using ketone body assay kit (Ketone Test
Sanwa, Sanwa Kagaku Co., Tokyo, Japan).
2.7. Cell culture
Mouse RAW 264 cells were grown in Dulbecco's modiﬁed Ea-
gle's medium (DMEM, Invitrogen) containing 4.5 mg/ml glucose
and supplemented with 10% heat-inactivated fetal bovine serum
(FBS, Invitrogen), then maintained at 37 C in an atmosphere of 5%
CO2. When the cells reached conﬂuence, they were induced to
differentiate into osteoclasts by changing to a differentiation me-
dium consisting of standard culture medium supplemented with
30 ng/ml RANKL (R & D systems, MN, U.S.A.) for 48 h. The medium
was changed twice and replaced with DMEM containing 10% FBS.
After 6 h, cells were treated with 0.5, 5, or 50 ng/ml IL-6 (R & D
systems) for 24 h.
MC3T3-E1 cells were cultured in a-modiﬁcation minimal
essential medium (a-MEM; Sigma, MO, U.S.A.) supplemented with
10% FBS in a humidiﬁed 5% CO2 incubator at 37 C. The cells were
cultured in a differentiation medium consisting of standard culture
medium supplemented with 5 mM b-glycerol phosphate (Sigma)
and 50 mg/ml L-ascorbic acid (Sigma). After 4 days, the cells were
treated with 0.5, 5, or 50 ng/ml IL-6 (R & D systems) for 24 h.
Tartrate-resistant acid phosphatase (TRAP) and alkaline phospha-
tase (ALP) staining was carried out using a TRAP/ALP Stain kit
(Wako Pure Chemical Industries).
2.8. RT-PCR
Aliquots of total RNA (4 mg) were isolated from B16 cells and
subjected to RT-PCR analysis of the antioxidant enzyme expression
using a set of primers speciﬁc for each enzyme, then analyzed with
Lumivision imager (AISIN SEIKI Co., Tokyo, Japan). The oligonucle-
otide primers used for ampliﬁcation were: forward (tccgcaaccatgtc
caagct) and reverse (atcacatgcacagctggatg) for mouse AACS, for-
ward (cgaagatggcggctctcaaa) and reverse (gatgcttcaagttgaaatct) for
mouse SCOT, forward (agagtttgaccgccttccga) and reverse (gtcagc-
cagacttcttcaga) for mouse HMGCR, forward (ccatggaggaggtggtgata)
and reverse (cgtctcgggatctctgctaa) for mouse FAS, and forward
(tgcaagagacttccatccag) and reverse (ttgccgagtagatctcaaag) for
mouse IL-6.
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All data are presented as the means ± SD and were analyzed
using unpaired Student's t-tests. p values < 0.05 were considered
statistically signiﬁcant.
3. Results
3.1. Ketone body utilizing enzyme was expressed in mouse bone
To investigate whether ketone bodies are utilized by AACS in
bone tissues, frozen sections of mouse embryos were analyzed by
in situ hybridization with an antisense AACS cRNA probe. Fig. 1
shows the results of autoradiography (Fig. 1A) of sagittal sections
of the mouse embryos (E 16.5). With the probes, discrete labeling
was observed in several regions of the embryo, including the brain,
heart, spinal cord, lung, small intestine and backbone region, andFig. 1. Distribution of AACS mRNA in mouse bone. a) Distribution of AACS mRNA in mouse em
examined using in situ hybridization with 35S-labeled AACS probes. E16.5 embryos were hyb
shown. Left: Embryonic backbone. Right: Magniﬁed view of the region indicated in the squar
spinal cord, L: lung, It: small intestine, Ba: backbone. b) Distribution of AACS mRNA in adult
old). The sections were examined using in situ hybridization with 35S-labeled each probe. T
eosin. Macroscopic and microscopic views are shown in the upper and lower panels, respe
(lower panels).particularly in the somite (Fig. 1A). In the developing vertebrate
embryo, somites split to form skeletal muscle, cartilage and bone.
Fig. 1B shows autoradiographs of sagittal sections of the mouse
femurs of postnatal mice (7 weeks old). In adult mice, AACS mRNA
was observed in the proximal and distal epiphysis of the femurs,
while SCOT, another ketone body-utilizing enzyme, was not
detected. In this region, osteocalcin and HMGCR mRNA expression
were also detected. Epiphysis is known as a region between the
growth plate and the extended end of the bone. Because osteo-
calcin is often used as a marker for the bone formation process, it is
possible that ketone bodies are utilized for bone metabolism by the
mevalonate pathway via AACS and HMGCR in this region.
3.2. HFD-induced obesity increased the gene expression of AACS
and IL-6 mRNA in osteoblasts
Recently, several reports have suggested that diet-inducedbryo. Sagittal sections were prepared from C57Bl/6 mouse embryos. The sections were
ridized with antisense AACS probes. Photomicrographs of emulsion-dipped sections are
e in the left panel. Scale bar ¼ 30 mm. B: brain, T: tongue, Th: thymus gland, H: heart, SC:
mouse femur. Sagittal sections were prepared from adult male C57Bl/6 mice (8 weeks
he sections were dipped in liquid emulsion and counter-stained with hematoxylin and
ctively. Box indicates the magniﬁed area. Scale bar ¼ 2 mm (upper panels) and 30 mm
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mellitus, one of the obesity-related diseases, causes bone loss and
impaired bone healing [18e20]. We have shown that the expres-
sion level of AACS mRNAwas signiﬁcantly affected by diet-induced
obesity and STZ-induced diabetes [21e23]. Because the serum level
of ketone bodies is increased by both diabetes and high-fat feeding,
it is possible that ketone bodies are used as metabolic substrates in
the bone by AACS and are related to dysfunctional bonemetabolismFig. 2. Effect of high-fat diet- and high-sucrose diet-induced obesity on mRNA expression o
with a normal diet (Con) or a high-fat diet (HFD) or a high-sucrose diet (HSD) for 12 weeks (n
of each time. b) Serum concentration of glucose and total ketone bodies. c) Gene expression
the femurs of control mice, HFD and HSD fed mice, and subjected to RT-PCR analysis. Each ex
is shown. Signiﬁcance: *, p < 0.05; **, p < 0.01; ***, p < 0.001 compared with the control.in high-fat diet-induced obese states. To clarify the effect of obesity
on the ketone body metabolism of bone, we investigated whether
the two different types of obesity affect the gene expression of
these enzymes in mouse femurs.
First, we investigated the effects of obesity on the gene
expression of ketone body-utilizing enzymes, using high-fat diet
(HFD)- and high-sucrose diet (HSD)-induced obese mice. Twelve
weeks of feeding the mice with the HFD or the HSD resulted inf ketone body-utilizing enzymes in mouse femurs. Four weeks old ddY mice were fed
¼ 4 mice per group). a) Body weights of control, HFD and HSD fed mice were measured
levels of ketone body-utilizing and lipogenic enzymes. Total RNAs were prepared from
pression level was normalized to the expression level of b-actin. The mean ± SD (n ¼ 4)
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approximately 1.5-fold (HFD) or 0.7-fold (HSD) increase in the
blood ketone body level (Fig. 2B) compared with feeding the
normal diet. In contrast, no differences were observed in the blood
glucose level (Fig. 2B).
Fig. 2C shows the gene expression levels of two ketone body-
utilizing enzymes, AACS and SCOT, in the femur. AACS mRNA
expression was higher in HFD-fed mice than in normal diet-fed
mice. However, such a difference was not observed in HSD-
induced obese rats. These HFD-speciﬁc increases were observed
in the HMGCR, fatty acid synthase (FAS) and interleukin (IL)-6
genes, but no differences in SCOT gene expression were observed
among the three diet groups. In contrast, the gene expression level
of osteocalcin was signiﬁcantly decreased only in HFD-fed mice.
Previous studies have demonstrated that obesity and diabetes,
which is also characterized as high concentration of serum ketone
bodies, causes bone marrow adiposity and bone resorption and0
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Fig. 3. Gene expression of ketone body-utilizing enzymes in osteoclasts and osteoblasts. A) L
or without (Non-induced cells) RANKL. TRAP-positive cells were counted as multinuclear ost
induced or induced RAW 264 cells and subjected to RT-PCR analysis. B) Left: ALP staining of d
RNAs were prepared from non-induced or induced MC3T3-E1 cells and subjected to RT-PCR
mean ± SD is shown. (n ¼ 4) Signiﬁcance: *, p < 0.05; **, p < 0.01; ***, p < 0.001 compareincreases the risk of developing osteoporosis [24]. On the other
hand, chronic inﬂammation causes a reduction in the bone mineral
density (BMD), which leads to osteopenia and osteoporosis [25].
Taken together, our results suggest that the HFD decreases bone
formation via inﬂammation of the bone marrow and also up-
regulates ketone body utilization for lipid synthesis in the bone
tissues.
3.3. HFD-induced inﬂammation induced AACS gene expression in
osteoclasts
Bone homeostasis is a highly coordinated process responsible
for bone resorption and formation [26]. Two main types of cells are
responsible for bone metabolism: osteoblasts (which secrete new
bone), and osteoclasts (which break bone down). To investigate the
cell speciﬁcity of AACS gene expression in bone tissues, we exam-
ined AACS gene expression in two cell lines, RAW 264 osteoclastsed cells Induced cells
AACS SCOT
d cells Induced cells
MGCR FAS
***
***
0
50
100
150
200
250
300
Non-Induced cells Induced cells
***
0
50
100
150
200
250
300
Non-Induced cells Induced cells
ced cells Induced cells
AACS SCOT
0
50
100
150
200
Non-induced cells Induced cells
eft: Number of TRAP-positive cells. RAW 264 cells were stimulated with (Induced cells)
eoclasts. Right: Gene expression of AACS and SCOT. Total RNAs were prepared from non-
ifferentiation-induced MC3T3-E1 cells. Right: Gene expression of AACS and SCOT. Total
analysis. Each expression level was normalized to the expression level of b-actin. The
d with the control.
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entiation marker of osteoclasts. AACS mRNA expression was
detected in undifferentiated cells and increased in differentiated
RAW 264 cells (Fig. 3A). Alterations in HMGCR and FAS gene
expression were also observed during osteoclast differentiation.
SCOT mRNA expression levels were not changed by the differenti-
ation. In MC3T3-E1 cells, no signiﬁcant changes were detected in
the gene expression of AACS and SCOT during osteoblast differen-
tiation (Fig. 3B). These results suggest that ketone bodies are
actively utilized in differentiated osteoclasts for the lipogenic
pathway via AACS, rather than in osteoblasts.Fig. 4. Effect of inﬂammatory cytokine on the gene expression of ketone body-utilizing enzym
(upper panel) and the gene expression of AACS and SCOT (lower panels). After IL-6 treatm
analysis. B) Effect of IL-6 on the gene expression of AACS and SCOT. After IL-6 treatmen
analysis. Con indicates the SCOT expression level in non-induced cells. Each expression
(n ¼ 4). Signiﬁcance: *, p < 0.05; **, p < 0.01; ***, p < 0.001 compared with the control.Human and animal experiments have implicated pro-
inﬂammatory cytokines, including IL-1, tumor necrosis factor-a
(TNF-a), and IL-6, as primary mediators of accelerated bone loss
[27]. Our data demonstrated that not only AACS but also IL-6 mRNA
expression was increased in femur bones by HFD feeding (Fig. 2C).
These results suggest that the HFD causes inﬂammatory responses
in bone, such as the up-regulation of IL-6 production, and one of
these responses might be the activation of ketone-lipid meta-
bolism. To clarify this possibility, we examined the effect of the IL-6
protein on AACS gene expression in osteoclast and osteoblast cell
lines (Fig. 4). After IL-6 treatment, AACS mRNA expression wases in osteoclasts and osteoblasts. A) Effect of IL-6 on the number of TRAP-positive cells
ent for 24 h, total RNAs were prepared from RAW 264 cells and subjected to RT-PCR
t for 24 h, total RNAs were prepared from MC3T3-E1 cells and subjected to RT-PCR
level was normalized to the expression level of b-actin. The mean ± SD is shown.
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positive cell number and SCOT mRNA expression level were not
changed by IL-6 treatment. On the other hand, in MC3T3-E1 cells,
no increase was observed in either AACS or SCOT (Fig. 4B). These
results suggest that inﬂammatory cytokines up-regulate AACS gene
expression in differentiated osteoclasts but not in osteoblasts.
4. Discussion
In the present study, we showed that the AACS gene was
expressed in bone, was mainly present in the epiphysis region, and
was induced by high-fat diet-induced obesity. This mRNA expres-
sion proﬁle was similar to that of HMGCR, which is known as the
rate-limiting enzyme for cholesterol synthesis; but such a proﬁle
was not observed for SCOT, which is known as the enzyme
responsible for the activation of ketone bodies for energy genera-
tion. These results suggest that HFD-induced obesity stimulates
ketone body utilization for the mevalonate pathway rather than
using ketone bodies as an energy source.
Moreover, we revealed that AACS gene expression was signiﬁ-
cantly up-regulated by IL-6 treatment only in osteoclasts, but the
number of TRAP-positive RAW 264 cells was not affected (Fig. 4A).
These facts suggest that the increase in AACS expression in the
femurs of HFD-induced obese mice is due to the inﬂammatory
activation of osteoclasts. Previous studies have demonstrated that
the HFD contributes to obesity in associationwith a state of chronic
inﬂammation [28]. Thus, an increase in IL-6 expression in whole
femurs (Fig. 2C) was due to the inﬂammatory response in the bone
caused by HFD feeding. Because abnormal activation of osteoclasts
by IL-6 causes an imbalance between bone resorption and bone
formation, IL-6 is one of the factors in osteoporosis [29]. HFD-
induced obesity correlates with a decrease in BMD [2,18]. There-
fore, an activation of ketone body utilization by IL-6 might stimu-
late bone resorption, and AACS likely plays an important role for the
relationship between osteoporosis and diet-induced obesity.
Our previous studies have demonstrated that knockdown of
AACS in vivo decreases total blood cholesterol, inhibits the differ-
entiation of 3T3-L1 cells and suppresses the expression of the
adipocyte markers, peroxisome proliferator-activated receptor g
(PPARg) and CCAAT/enhancer binding protein a (C/EBPa) [11,12].
These results suggest that ketone body metabolism via AACS ac-
tivity plays an important role not only in cholesterol homeostasis
but also in adipogenic differentiation. Motyl et al. demonstrated
that the C/EBP family enhances bone marrow adiposity and bone
resorption [30]. Mirzaei et al. reported that serum IL-6 was signif-
icantly higher in an osteopenic group than a non-osteopenic group,
and over expression of PPARg in obese humans may have a critical
role in relationship between obesity and bone loss [31]. Taken
together, it is possible that AACS plays a key role in bone marrow
adiposity during obese state via the activation of adipogenic tran-
scriptional factors, such as C/EBP family and PPARg. Furthermore,
cholesterol biosynthesis, which is controlled by HMGCR activity, is
a key factor in isoprenoid-dependent IL-6 mediated inﬂammation
[32], and anti-HMGCR drug statins enhance new bone formation in
rodents [14]. Because the AACS expression pattern was similar to
that of HMGCR in the bones of HFD-induced obese mice and IL-6-
induced inﬂammatory osteoclasts, ketone body utilization via
AACS may contribute to the ossiﬁcation effect of statins. Further
studies are recommended to clarify the role of AACS in osteoclasts
and bone metabolism.
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